DiscoveRx Corporation

[email protected]

+44 (0)121 260 6142


DiscoveRx is a leading provider of next generation proprietary platforms for both target-based and phenotypic drug discovery. The company holds extensive intellectual property for its core technology platforms, which have been utilized to develop and commercialize industry leading panels of over 1,000 target-based and primary cell based assay solutions for Oncology, Metabolic Disease, Inflammation, CNS and Cardiovascular drug discovery research. Many of DiscoveRx’s innovative solutions have been widely adopted in pharmaceutical, biotechnology and academic laboratories worldwide.